Wells Fargo’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.87M Sell
14,988
-16,584
-53% -$4.41M ﹤0.01% 2806
2025
Q4
$7.78M Buy
31,572
+11,919
+61% +$2.51M ﹤0.01% 2263
2025
Q3
$3.47M Buy
19,653
+3,106
+19% +$465K ﹤0.01% 2885
2025
Q2
$2.27M Sell
16,547
-588
-3% -$86.4K ﹤0.01% 3133
2025
Q1
$3.09M Buy
17,135
+207
+1% +$34.8K ﹤0.01% 2796
2024
Q4
$2.65M Buy
16,928
+2,972
+21% +$527K ﹤0.01% 2975
2024
Q3
$2.54M Sell
13,956
-534
-4% -$103K ﹤0.01% 2869
2024
Q2
$2.66M Buy
14,490
+5,332
+58% +$895K ﹤0.01% 2754
2024
Q1
$1.63M Buy
9,158
+1,598
+21% +$222K ﹤0.01% 3137
2023
Q4
$938K Sell
7,560
-12,433
-62% -$1.38M ﹤0.01% 3471
2023
Q3
$2.32M Sell
19,993
-1,720
-8% -$210K ﹤0.01% 2692
2023
Q2
$2.55M Buy
21,713
+3,528
+19% +$360K ﹤0.01% 2706
2023
Q1
$1.46M Buy
18,185
+13,915
+326% +$1.09M ﹤0.01% 3125
2022
Q4
$338K Sell
4,270
-647
-13% -$48K ﹤0.01% 3876
2022
Q3
$343K Sell
4,917
-386
-7% -$27.9K ﹤0.01% 3923
2022
Q2
$348K Sell
5,303
-4,317
-45% -$269K ﹤0.01% 3965
2022
Q1
$640K Sell
9,620
-5,345
-36% -$334K ﹤0.01% 4231
2021
Q4
$1.05M Buy
14,965
+9,288
+164% +$541K ﹤0.01% 4063
2021
Q3
$296K Buy
5,677
+5,472
+2,669% +$324K ﹤0.01% 4940
2021
Q2
$14K Sell
205
-1,489
-88% -$104K ﹤0.01% 6036
2021
Q1
$130K Sell
1,694
-12,280
-88% -$893K ﹤0.01% 5363
2020
Q4
$839K Sell
13,974
-11,337
-45% -$566K ﹤0.01% 4160
2020
Q3
$1.09M Sell
25,311
-175,211
-87% -$7.61M ﹤0.01% 3790
2020
Q2
$8.31M Buy
200,522
+68,105
+51% +$3.28M ﹤0.01% 2010
2020
Q1
$5.72M Buy
132,417
+88,438
+201% +$4.63M ﹤0.01% 2123
2019
Q4
$2.44M Buy
43,979
+27,422
+166% +$1.35M ﹤0.01% 3194
2019
Q3
$575K Buy
16,557
+7,102
+75% +$317K ﹤0.01% 4274
2019
Q2
$381K Buy
9,455
+280
+3% +$9.15K ﹤0.01% 4571
2019
Q1
$302K Buy
9,175
+245
+3% +$5.78K ﹤0.01% 4618
2018
Q4
$185K Buy
8,930
+8,630
+2,877% +$181K ﹤0.01% 4962
2018
Q3
$5K Hold
300
﹤0.01% 6118
2018
Q2
$4K Buy
+300
New +$3.37K ﹤0.01% 6108

Other funds holding KRYS